CN104824019A - 具有低过氧含量的水性卫生洗涤剂、消毒剂和/或杀菌剂 - Google Patents
具有低过氧含量的水性卫生洗涤剂、消毒剂和/或杀菌剂 Download PDFInfo
- Publication number
- CN104824019A CN104824019A CN201510115387.XA CN201510115387A CN104824019A CN 104824019 A CN104824019 A CN 104824019A CN 201510115387 A CN201510115387 A CN 201510115387A CN 104824019 A CN104824019 A CN 104824019A
- Authority
- CN
- China
- Prior art keywords
- disinfectant
- composition
- peroxide
- alcohol
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000645 desinfectant Substances 0.000 title claims abstract description 145
- 239000000203 mixture Substances 0.000 claims abstract description 147
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 42
- 229910052723 transition metal Inorganic materials 0.000 claims abstract description 24
- 150000003624 transition metals Chemical class 0.000 claims abstract description 24
- 239000000956 alloy Substances 0.000 claims abstract description 19
- 229910045601 alloy Inorganic materials 0.000 claims abstract description 19
- 230000002421 anti-septic effect Effects 0.000 claims description 36
- 239000008365 aqueous carrier Substances 0.000 claims description 30
- 150000002978 peroxides Chemical class 0.000 claims description 29
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 28
- 150000004965 peroxy acids Chemical class 0.000 claims description 14
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 5
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 claims description 4
- 150000004972 metal peroxides Chemical class 0.000 claims description 4
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 claims description 3
- 239000004343 Calcium peroxide Substances 0.000 claims description 2
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 claims description 2
- ZJRXSAYFZMGQFP-UHFFFAOYSA-N barium peroxide Chemical compound [Ba+2].[O-][O-] ZJRXSAYFZMGQFP-UHFFFAOYSA-N 0.000 claims description 2
- 125000001246 bromo group Chemical group Br* 0.000 claims description 2
- 235000019402 calcium peroxide Nutrition 0.000 claims description 2
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- 229940045872 sodium percarbonate Drugs 0.000 claims description 2
- UHCGLDSRFKGERO-UHFFFAOYSA-N strontium peroxide Chemical compound [Sr+2].[O-][O-] UHCGLDSRFKGERO-UHFFFAOYSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract description 21
- 239000008135 aqueous vehicle Substances 0.000 abstract description 8
- 150000001299 aldehydes Chemical class 0.000 abstract description 7
- 235000013305 food Nutrition 0.000 abstract description 6
- 239000000243 solution Substances 0.000 description 77
- 239000000725 suspension Substances 0.000 description 69
- 238000012360 testing method Methods 0.000 description 44
- 239000007788 liquid Substances 0.000 description 39
- 230000001954 sterilising effect Effects 0.000 description 33
- 238000010790 dilution Methods 0.000 description 28
- 239000012895 dilution Substances 0.000 description 28
- 238000004659 sterilization and disinfection Methods 0.000 description 27
- 239000000499 gel Substances 0.000 description 24
- 238000000034 method Methods 0.000 description 22
- 238000011081 inoculation Methods 0.000 description 21
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 19
- 239000004744 fabric Substances 0.000 description 18
- 238000005374 membrane filtration Methods 0.000 description 18
- 229910052709 silver Inorganic materials 0.000 description 18
- 239000004332 silver Substances 0.000 description 18
- 230000004083 survival effect Effects 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- 241000193830 Bacillus <bacterium> Species 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 16
- 229910052751 metal Inorganic materials 0.000 description 16
- 239000002184 metal Substances 0.000 description 16
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 15
- 229960000587 glutaral Drugs 0.000 description 15
- 230000002147 killing effect Effects 0.000 description 14
- -1 aliphatic alcohols Chemical class 0.000 description 13
- 150000001298 alcohols Chemical class 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 238000005406 washing Methods 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 244000063299 Bacillus subtilis Species 0.000 description 9
- 235000014469 Bacillus subtilis Nutrition 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 241000186366 Mycobacterium bovis Species 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 229960005150 glycerol Drugs 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 230000000845 anti-microbial effect Effects 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 239000007382 columbia agar Substances 0.000 description 8
- 230000000249 desinfective effect Effects 0.000 description 8
- 239000003349 gelling agent Substances 0.000 description 8
- 239000002324 mouth wash Substances 0.000 description 8
- 229940051866 mouthwash Drugs 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- 239000007921 spray Substances 0.000 description 8
- 239000003899 bactericide agent Substances 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 239000006260 foam Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000004743 Polypropylene Substances 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 6
- 229920001155 polypropylene Polymers 0.000 description 6
- 229920000053 polysorbate 80 Polymers 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 238000013207 serial dilution Methods 0.000 description 6
- 239000000344 soap Substances 0.000 description 6
- 239000012085 test solution Substances 0.000 description 6
- 229940034610 toothpaste Drugs 0.000 description 6
- 239000000606 toothpaste Substances 0.000 description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 5
- 241001116389 Aloe Species 0.000 description 5
- 102000016938 Catalase Human genes 0.000 description 5
- 108010053835 Catalase Proteins 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 239000000443 aerosol Substances 0.000 description 5
- 235000011399 aloe vera Nutrition 0.000 description 5
- 238000000889 atomisation Methods 0.000 description 5
- 239000000084 colloidal system Substances 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000000787 lecithin Substances 0.000 description 5
- 235000010445 lecithin Nutrition 0.000 description 5
- 229940067606 lecithin Drugs 0.000 description 5
- 239000003595 mist Substances 0.000 description 5
- 125000000864 peroxy group Chemical group O(O*)* 0.000 description 5
- 150000003839 salts Chemical group 0.000 description 5
- 238000011012 sanitization Methods 0.000 description 5
- 239000002562 thickening agent Substances 0.000 description 5
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000006386 neutralization reaction Methods 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 238000001223 reverse osmosis Methods 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 4
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical compound NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229910001316 Ag alloy Inorganic materials 0.000 description 3
- 241000193738 Bacillus anthracis Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 244000299507 Gossypium hirsutum Species 0.000 description 3
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 3
- 241000186359 Mycobacterium Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229960003067 cystine Drugs 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000002923 metal particle Substances 0.000 description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- CZPZWMPYEINMCF-UHFFFAOYSA-N propaneperoxoic acid Chemical compound CCC(=O)OO CZPZWMPYEINMCF-UHFFFAOYSA-N 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 239000001974 tryptic soy broth Substances 0.000 description 3
- 108010050327 trypticase-soy broth Proteins 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- IKYKEVDKGZYRMQ-PDBXOOCHSA-N (9Z,12Z,15Z)-octadecatrien-1-ol Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCO IKYKEVDKGZYRMQ-PDBXOOCHSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 238000012371 Aseptic Filling Methods 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 229910000914 Mn alloy Inorganic materials 0.000 description 2
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- ACIAHEMYLLBZOI-ZZXKWVIFSA-N Unsaturated alcohol Chemical compound CC\C(CO)=C/C ACIAHEMYLLBZOI-ZZXKWVIFSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 239000011928 denatured alcohol Substances 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002650 laminated plastic Substances 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 239000006194 liquid suspension Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- BHTJEPVNHUUIPV-UHFFFAOYSA-N pentanedial;hydrate Chemical compound O.O=CCCCC=O BHTJEPVNHUUIPV-UHFFFAOYSA-N 0.000 description 2
- 238000002135 phase contrast microscopy Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000013464 silicone adhesive Substances 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- CFOQKXQWGLAKSK-KTKRTIGZSA-N (13Z)-docosen-1-ol Chemical class CCCCCCCC\C=C/CCCCCCCCCCCCO CFOQKXQWGLAKSK-KTKRTIGZSA-N 0.000 description 1
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical class Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 description 1
- JXNPEDYJTDQORS-AVQMFFATSA-N (9e,12e)-octadeca-9,12-dien-1-ol Chemical compound CCCCC\C=C\C\C=C\CCCCCCCCO JXNPEDYJTDQORS-AVQMFFATSA-N 0.000 description 1
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- CFOQKXQWGLAKSK-UHFFFAOYSA-N 13-docosen-1-ol Chemical class CCCCCCCCC=CCCCCCCCCCCCCO CFOQKXQWGLAKSK-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- IKYKEVDKGZYRMQ-IUQGRGSQSA-N 9,12,15-Octadecatrien-1-ol Chemical compound CC\C=C\C\C=C\C\C=C\CCCCCCCCO IKYKEVDKGZYRMQ-IUQGRGSQSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910000881 Cu alloy Inorganic materials 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 238000006424 Flood reaction Methods 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- LTGPFZWZZNUIIK-LURJTMIESA-N Lysol Chemical compound NCCCC[C@H](N)CO LTGPFZWZZNUIIK-LURJTMIESA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000710886 West Nile virus Species 0.000 description 1
- RQCJDSANJOCRMV-UHFFFAOYSA-N [Mn].[Ag] Chemical compound [Mn].[Ag] RQCJDSANJOCRMV-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229910001423 beryllium ion Inorganic materials 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- LBAYFEDWGHXMSM-UHFFFAOYSA-N butaneperoxoic acid Chemical compound CCCC(=O)OO LBAYFEDWGHXMSM-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- GHZFPSVXDWJLSD-UHFFFAOYSA-N chromium silver Chemical compound [Cr].[Ag] GHZFPSVXDWJLSD-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-UHFFFAOYSA-N cis-oleyl alcohol Natural products CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- IYRDVAUFQZOLSB-UHFFFAOYSA-N copper iron Chemical compound [Fe].[Cu] IYRDVAUFQZOLSB-UHFFFAOYSA-N 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229910001254 electrum Inorganic materials 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- XXOYNJXVWVNOOJ-UHFFFAOYSA-N fenuron Chemical compound CN(C)C(=O)NC1=CC=CC=C1 XXOYNJXVWVNOOJ-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000021393 food security Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- YVJRCWCFDJYONJ-UHFFFAOYSA-N hydroperoxymethylbenzene Chemical compound OOCC1=CC=CC=C1 YVJRCWCFDJYONJ-UHFFFAOYSA-N 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- SJCKRGFTWFGHGZ-UHFFFAOYSA-N magnesium silver Chemical compound [Mg].[Ag] SJCKRGFTWFGHGZ-UHFFFAOYSA-N 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 229940124561 microbicide Drugs 0.000 description 1
- 239000002855 microbicide agent Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- LBIYNOAMNIKVKF-FPLPWBNLSA-N palmitoleyl alcohol Chemical compound CCCCCC\C=C/CCCCCCCCO LBIYNOAMNIKVKF-FPLPWBNLSA-N 0.000 description 1
- LBIYNOAMNIKVKF-UHFFFAOYSA-N palmitoleyl alcohol Natural products CCCCCCC=CCCCCCCCCO LBIYNOAMNIKVKF-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 229960004029 silicic acid Drugs 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- 229940071575 silver citrate Drugs 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229960001516 silver nitrate Drugs 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- QUTYHQJYVDNJJA-UHFFFAOYSA-K trisilver;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Ag+].[Ag+].[Ag+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QUTYHQJYVDNJJA-UHFFFAOYSA-K 0.000 description 1
- MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/38—Percompounds, e.g. peracids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
- A61L2/186—Peroxide solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/02—Inorganic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/02—Inorganic compounds
- C11D7/04—Water-soluble compounds
- C11D7/06—Hydroxides
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/261—Alcohols; Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Wood Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及消毒剂组合物,其是对人安全的,例如是食品级或食品安全的。在一个实施方式中,水性消毒剂组合物可包含水性载体,所述水性载体包括水、从0.001wt%至10.0wt%的过氧和醇类。另外,基于所述水性载体含量还可以存在按重量计算从0.001ppm至50,000ppm的过渡金属。该组合物可以基本不含醛。可选地或附加地,所述过渡金属可以具有胶体过渡金属的形式,例如胶体银或其合金。
Description
本申请是分案申请,原申请的申请日为2007年8月22日、申请号为200780035643.8(PCT/US2007/018606)、发明名称为“具有低过氧含量的水性卫生洗涤剂、消毒剂和/或杀菌剂”。
发明领域
本发明涉及能被用于包括硬表面清洁在内的各种目的并且有效作为消毒剂的消费者安全组合物。
发明背景
消毒剂,例如硬表面消毒剂,被广泛用于家用环境和专业环境。示例性的常用硬表面清洁剂是消毒剂。尽管对于许多应用有效,但在降低细菌内生孢子的水平方面不如商购可得的戊二醛水溶液有效。戊二醛水溶液广泛用作消毒剂,并且通常可以1wt%和2wt%溶液获得,尤其是在医疗和牙科环境中。戊二醛溶液一般被用于更精密的医疗/牙科仪器,其否则将易于受其它灭菌方法例如高压灭菌损坏。然而,戊二醛也是一种强刺激物和呼吸致敏物。事实上,已有个体由于烟雾而致敏的报告,其导致呼吸性问题、头痛、昏睡、皮肤脱色等等。因为这些与戊二醛烟雾相关的问题,必须经常监视空气质量,或者必须提供适当的空气通风。结果,尽管戊二醛溶液是相对有效的消毒剂,但期望提供可展示出甚至更有效的细菌杀死水平同时对于使用消毒剂的个体更安全的组合物。
发明概述
已经认识到,期望提供对于清洁表面、特别是硬表面有效的液体溶液和分散消毒剂。据此,水性消毒剂组合物可包含水性载体,所述水性载体包括水、从0.001wt%至10.0wt%的过氧、和醇类。另外,基于所述水性载体含量还可以存在按重量计从0.001ppm至50,000ppm的过渡金属,条件是消毒剂组合物基本上不含醛。
在另一个实施方式中,水性消毒剂组合物可包含水性载体,水性载体包括水、从0.001wt%至10.0wt%的过氧、和醇类。所述组合物可以进一步包含基于水性载体含量按重量计从0.001ppm至50,000ppm的胶体银或其合金。
在另一个实施方式中,消毒表面的方法可包括使所述表面与消毒剂组合物接触,所述消毒剂组合物包含水性载体,水性载体包括水、从0.001wt%至10.0wt%的过氧、和醇类。所述组合物可以进一步包含基于水性载体含量按重量计从0.001ppm至50,000ppm的过渡金属或其合金。
从下文以举例方式阐述本发明的特征的详细描述,本发明的另外的特征和优点将是明显的。
优选实施方式详细描述
现在参考示例性实施方式,并且在本文中特定语言将用于描述相同的对象。然而,应该理解,不因此意图限制本发明的范围。相关领域的并掌握本公开内容的普通技术人员将想到的本文阐述的发明特征的改变和进一步修改以及本文阐述的发明原理的其它应用将被认为在本发明的范围之内。还应理解,本文所用的术语仅被用于描述具体实施方式的目的。所述术语不意图是限制性的,除非如此说明。
必须指出,当用于说明书和所附权利要求书时,单数形式的“一(a)”、“一(an)”和“该(the)”包括复数对象,除非所述内容另外清楚地规定。
当对于本发明的组合物而使用时,术语“食品级”是指组合物基本上不含公认安全水平之上的、被认为在消费后对于哺乳动物有害的或具有毒性的成分。
通常,尽管卫生洗涤剂、杀菌剂和消毒剂用于相同的目的,即杀死细菌和/或病毒等等,但杀菌剂组合物与消毒剂相比展示出更大的杀灭水平,所述消毒剂又具有比卫生洗涤剂更好的杀灭水平。这就是说,大多数应用仅仅要求卫生洗涤剂或消毒剂水平的细菌/病毒减少,尽管其它应用显著受益于杀菌剂的应用。为了方便起见,在本公开中,术语“消毒剂”被一般性应用,并包括卫生洗涤剂、消毒剂和杀菌剂,除非上下文另外规定。
术语“溶液”也在整篇说明书中使用,以描述本发明的液体组合物。然而,因为这些“溶液”可包括胶体过渡金属,所有这些组合物还可被描述为分散液或悬浮液。因为连续相一般是溶液,并且过渡金属可以离子和/或胶体形式存在,为了方便起见,这些组合物在本文中通常被称为“溶液”。
当对于本发明的消毒剂组合物而言使用时,术语“基本上不含”是指具体化合物或成分的全部不存在或接近全部不存在。例如,当组合物被描述为基本上不含醛时,则在所述组合物中或者不存在醛或者在所述组合物中仅仅存在痕量的醛。
术语“过氧(peroxygen)”是指包含双氧(O-O)键的任何化合物。双氧键,特别是二价O-O键,可容易断裂,从而允许包含它们的化合物充当有效的氧化剂。过氧化合物类的非限制例子包括过酸、过酸盐、和过氧化物例如过氧化氢。
当提及术语“合金”时,可以理解,单个胶体或金属颗粒可以具有多金属的复合物的形式,或者合金还可包括作为分离颗粒的多金属的共分散液。
浓度、尺寸、数量、及其它数值数据在本文中可以范围形式给出。可以理解,这样的范围形式仅仅为了方便和简洁起见而使用,并且应该灵活地解释成不仅包括该范围的边界所明确描述的数值,而且包括该范围内包括的各个数值或子区间,如同各数值和子区间被明确描述一样。例如,约1wt%至约20wt%的重量比范围应该解释成不仅包括明确描述的1wt%和约20wt%的边界,而且包括各个重量例如2wt%、11wt%、14wt%,以及子区间例如10wt%至20wt%、5wt%至15wt%等等。
据此,水性消毒剂组合物可包含水性载体,水性载体包括水、从0.001wt%至10.0wt%的过氧、和醇类。另外,基于所述水性载体含量还可以存在按重量计从0.001ppm至50,000ppm的过渡金属,条件是消毒剂组合物基本上不含醛。在另一个实施方式中,水性消毒剂组合物可包含水性载体,水性载体包括水、从0.001wt%至10.0wt%的过氧、和醇类。所述组合物可以进一步包含基于水性载体含量按重量计从0.001ppm至50,000ppm的胶体银或其合金。在又一个的实施方式中,消毒表面的方法可包括使所述表面与消毒剂组合物接触,所述消毒剂组合物包含水性载体,水性载体包括水、从0.001wt%至10.0wt%的过氧、和醇类。所述组合物可以进一步包含基于水性载体含量按重量计从0.001ppm至50,000ppm的过渡金属或其合金。
注意,根据本发明的具体实施方式,过氧的范围的下限可以更改至0.05wt%或0.1wt%,和/或该范围的上限可以更改至5wt%、3wt%或1.5wt%。还注意,在此处,醇类在无范围限制的情况下给出,但在一个具体实施方式中,可以以0.001wt%至95wt%存在。这就是说,根据本发明的具体实施方式,醇类的范围的下限可以更改至0.05wt%或0.1wt%,和/或该范围的上限可以更改至40wt%、30wt%、20wt%或10wt%。此外,金属内容物——包括离子和/或胶体内容物——的浓度还可以在所述范围的下限改变至按重量计10ppm,和/或在所述范围的上限改变至按重量计10,000ppm、5,000ppm或1500ppm。因为这些范围仅仅是示例性的,所以对于具体应用,考虑了诸如醇类型(多元的、食品级、混合型等等);过氧类型(过氧化物、过酸、过氧化物/过酸的组合等等);和金属的类型(离子、胶体、合金等等)的情况,本领域普通技术人员可以改变这些范围。
在一个具体实施方式中,消毒剂组合物可以仅仅包括食品级或食品安全的成分。例如,尽管不要求,所述组合物可以基本上不含通常存在于许多商购可得的表面清洁剂中的消毒剂成分。可以从本发明的消毒剂中省略的非食品级成分的例子包括但是不限于醛例如戊二醛;氯基消毒剂;氯和溴基消毒剂;碘递体(iodophore)基消毒剂;酚基消毒剂、季铵基消毒剂;等等。
水性载体可任选地包括其它成分例如有机共溶剂。特别地,某些醇类可以存在。例如,可以使用醇类,包括脂族醇及其它含碳醇,其具有1至24个碳(C1-C24醇)。应当注意,“C1-C24醇”不必仅仅意味着直链饱和脂族醇,因为其它含碳醇也可以在此定义中使用,包括支化脂族醇、脂环族醇、芳醇、不饱和醇以及取代的脂肪族、脂环族、芳香族和不饱和醇等等。在一个实施方式中,所述脂族醇可以是C1至C5醇,包括甲醇、乙醇、丙醇和异丙醇、丁醇、和戊醇,原因在于它们容易得到和较低的沸点。这就是说,多元醇还可以有效用于增强本发明的组合物的消毒剂和杀菌剂效力,以及提供一定程度的附加稳定化。可被用于本发明的多元醇的例子包括但不限于乙二醇(乙烷-1,2-二醇)、甘油(或丙三醇、丙烷-1,2,3-三醇)、和丙烷-1,2-二醇。其它非脂族醇也可被使用,包括但不限于酚和取代酚、瓢儿菜醇、蓖麻醇、花生醇、辛醇、癸醇、山萮醇、月桂醇(1-十二烷醇)、肉豆蔻醇(1-十四烷醇)、鲸蜡基(或棕榈基)醇(1-十六醇)、硬脂醇(1-十八醇)、异硬脂醇、油醇(顺式-9-十八烯-1-醇)、棕榈油醇、亚油酸醇(9Z,12Z-十八碳二烯-1-醇)、反式十八烯醇(9E-十八烯-1-醇)、反油酸亚油酸醇(elaidolinoleylalcohol)(9E,12E-十八碳二烯-1-醇)、亚麻醇(9Z,12Z,15Z-十八碳三烯-1醇)、反油酸亚麻醇(elaidolinolenylalcohol)(9E,12E,15-E-十八碳三烯-1-醇)、其组合、等等。
在一些实施方式中,出于实际考虑,通常可优选使用甲醇、乙醇、和变性酒精(乙醇和较小量的甲醇、以及任选的少量苯、酮、乙酸酯等等的混合物),原因在于它们容易得到和成本。丙三醇也可用于一些实施方式中。如果期望提供食品级组合物,则可以选择满足此要求的醇。当考虑醇类的使用量时,对于具体应用,考虑诸如所选择使用的醇是否是多元的、所述醇是否是食品级、醇混合物等情况,本领域普通技术人员可以维持以上所述范围,或改变这些范围。
对于过渡金属,根据本发明的实施方式,所述金属可以是离子形式(例如离解金属盐、元素金属的金属离子等等)和/或胶体形式。在一个具体实施方式中,过渡金属可以是亚微米形式(即小于1μm的金属胶体微粒的分散液)。然而,较大的胶体过渡金属粒子也可以用于某些应用。期望使用的典型过渡金属包括VI族至XI族过渡金属,并且更优选地,可以包括X族至XI族过渡金属。还可以使用包括来自VI族至XI族金属的至少一种金属的合金。认识到,这些金属的任何一种通常在过氧存在的情况下被氧化成相应的阳离子。然而,一般地,采用胶体金属,表面通常对这样的氧化更敏感。此外,当胶体金属分散在胶体溶液中时,经常存在一定量的也存在于悬浮液中的离子或盐形式的金属。例如,胶体银可以在溶液中包括某一百分数的银盐或离子银,例如,基于总金属含量,按重量计10%至90%的金属含量可以是离子。这就是说,根据本发明的实施方式可用的某些优选的金属是钌、铑、锇、铱、钯、铂、铜、金、银、其合金、以及其混合物。银通常是最优选的,但是金属选择在某种程度上可依赖于应用、所期望或要求的杀死水平、针对的病原体的类型、所清洁的基底等等。
还注意,任何这些实施方式通常也可受益于合金的应用。例如,在合金中金属的某些组合对于具体病原体可提供可接受的杀死水平,并且还提供与次要考虑因素例如溶液稳定性、待清洁基底等等更相关的益处。用于本发明的过渡金属合金的优选例子包括但不限于铜银合金、银锰合金、铁铜合金、铬银合金、金银合金、镁银合金等等。
可被使用的示例性胶体银包括由Solutions IE,Inc.以商品名CSPlus和C S Ultra.出售的那些。可被用作银来源的其它胶体银产品包括ASAP、Sovereign Silver、Silver Max等等。在一个实施方式中,用于本发明的胶体微粒可以具有0.001μm至1.0μm的粒径范围。在另一个实施方式中,胶体过渡金属粒子可以具有0.030μm至0.5μm.的大小范围。在仍另一个实施方式中,平均粒径是0.35μm至0.45μm。如果以离子形式使用,优选的银盐包括但不限于硝酸银、乙酸银、柠檬酸银、氧化银和/或碳酸银。尽管可以使用用于本发明的制剂中发挥作用的许多胶体银溶液或离子银溶液,但在一个实施方式中,可以期望使用RO水(反渗透水)作为与其它成分混合的胶体和/或离子银的悬浮介质。在更详细的方面,RO水还可以进行蒸馏,得到18-20MΩ的水,尽管这并不要求。
消毒剂溶液的过氧组分可以是单一化合物或多种过氧化合物或过氧形成化合物的组合。在一个实施方式中,过氧可以是任何脂肪族或芳香族过酸(或过氧酸),其根据本发明的实施方式对于消毒剂目的而言具有功能。虽然任何功能性过酸可被使用,但包含1至7个碳的过酸对于应用是最实际的。这些过酸可以包括但不限于过甲酸、过乙酸、过草酸、过丙酸、过乳酸、过丁酸、过戊酸、过己酸、过己二酸、过柠檬酸和/或过苯甲酸。用于本发明的过酸可以使用本领域已知的任何方法制备。当过酸从酸和过氧化氢制备时,所得到的混合物包含过酸和由其制备过酸的相应酸两者。例如,在利用过乙酸的实施方式中,有关酸(乙酸)的存在提供稳定性给所述混合物,因为该反应是在所述酸、过氧化氢以及过酸和水之间的平衡,如下:
过酸盐例如以上所列过酸的盐也可以被包括,作为消毒剂溶液的过氧组分。这样的盐的非限制例子包括高锰酸盐、过硼酸盐、高氯酸盐、过醋酸盐、过碳酸盐、过硫酸盐等等。所述盐可被单独或彼此联合或与其它过氧化合物联合使用,以形成本发明的过氧组分。
在另一个实施方式中,本发明的过氧组分可以包括过氧化物化合物。虽然过氧化氢被认为是可按照本发明的实施方式使用的期望过氧化物,其它过氧化物也可以被使用,例如金属过氧化物和过氧化水合物(peroxyhydrates)。可被使用的金属过氧化物包括但是不限于过氧化钠、过氧化镁、过氧化钙、过氧化钡和/或过氧化锶。其它盐(例如过碳酸钠)具有以很像水合水的方式与之结合的过氧化氢,并且这些也可以被认为是过氧化氢的来源,从而原位产生过氧化氢。如上述,所述过氧化物可被单独或与其它过氧化合物联合使用,以形成本发明的过氧组分。
本发明的消毒剂组合物可以混合入其它成分,以形成各种消毒剂产品,包括但不限于洗手剂、嗽口水、外科擦洗液(surgical scrub)、身体喷雾(body splash)、手用卫生洗涤剂凝胶和泡沫、消毒擦抹布和类似的个人护理产品。其它类型的产品包括消毒剂泡沫、膏、摩丝等等,以及包含有机和无机填料的组合物,例如乳液、洗液、乳膏、糊剂等等。所述组合物进一步可被用作硬表面的抗菌清洁剂,例如在浴室、医院、水池和工作台面、饮食服务区以及肉类加工厂中。所述消毒剂组合物还可以用作消毒雾和消毒剂薄雾。本抗菌组合物可以被制造为稀释的即用型组合物或者为可以在使用前稀释的浓缩物。其中使用消毒剂的各种产品还可以包括香料,这取决于所述产品的特性。例如,松木或柠檬香料对于厨房清洁擦抹布的应用可以是期望的,原因在于对于清洁度它们对许多消费者具有吸引力。此外,凝胶剂或气雾剂也可由于类似或其它理由而添加香料。
在本发明的一个实施方式中,消毒剂组合物用来制造消毒擦抹布。本发明的消毒擦抹布可用于清洁各种坚固表面和其它表面,包括人手和皮肤、医疗器械、工作台面、水池、地板、墙、窗等等。本发明的擦抹布可由各种织物制备。为了本发明的目的,织物可包括布和纸、以及织造和非织造材料。织造或非织造织物可由适当的材料例如人造纤维、尼龙、或棉、其组合制成。非织造织物的例子被描述在美国专利3,786,615;4,395,454;和4,199,322中;它们通过引用由此并入。所述织物或纸可以通过本领域已知的任何方法用所述消毒剂溶液浸渍。所述擦抹布可以以本领域已知的任何方式包装,包括单独泡罩型包装或者缠绕式多包装或堆叠式多包装。
在另一个实施方式中,本发明的消毒剂组合物被配制成凝胶或凝胶状卫生处理组合物。除消毒剂组合物之外,本发明的凝胶卫生洗涤剂可以包括增稠剂或胶凝剂,其中“增稠剂”和“胶凝剂”可互换使用。为了本发明的目的,术语“凝胶”或“凝胶状”卫生处理组合物是指消毒液体物质,其可具有从约1,000厘泊至约100,000厘泊的粘度,或者在另一个实施方式中具有从2,000厘泊至50,000厘泊的粘度,尽管这些范围不意图是限制性的。例如,手用凝胶可具有比用于工业清洗或消毒剂目的的凝胶显著较低的粘性。胶凝剂或增稠剂的例子包括但不限于天然树胶例如瓜尔胶和瓜尔胶衍生物、合成聚合物、粘土、油、蜡、芦荟胶、丙烯酸酯均聚物、丙烯酸酯共聚物、卡波姆、纤维素、纤维素衍生物、褐藻胶、褐藻胶衍生物、水不溶性C8-C20醇、角叉菜胶、火成二氧化硅、其混合物等等。胶凝剂可以以凝胶状组合物的约0.1wt%至50wt%的量存在于凝胶状卫生处理组合物中。在另一个实施方式中,胶凝剂以凝胶状组合物的0.25wt%至10wt%的量存在。胶凝剂的量可以取决于各种因素,包括胶凝剂的类型和所述凝胶的期望粘度。凝胶状的卫生洗涤剂可被用于各种应用,包括人皮肤的卫生处理,例如,凝胶手用卫生洗涤剂、和硬表面卫生处理。在一个具体实施方式,消毒剂组合物可以与天然芦荟凝胶混合,形成消毒芦荟制剂。这样的制剂将可用于烧伤、皮肤感染及其它刺激。芦荟可以充当增稠剂,或也可以包括另一种如上所述的增稠剂或胶凝剂,这取决于该消毒凝胶的期望粘度。
在另一个实施方式中,本发明的消毒剂组合物可被配制成消毒泡沫或起泡组合物。该消毒泡沫或起泡组合物包括消毒剂组合物和起泡剂。本领域已知的任何起泡剂可被使用,这取决于所得消毒泡沫的期望应用和特征。如同消毒剂组合物,本发明的消毒泡沫可被用于人(例如洗手)和工业应用。
在另一个实施方式中,本发明的消毒剂组合物可具有消毒气雾剂或喷雾的形式。雾化,也被称为热雾化,是消毒剂雾化的过程。所述消毒剂的气溶胶颗粒被悬于空气内一段时间,以消毒空气本身和表面两者,所述表面包括建筑物的难接近部分,例如通风孔。消毒剂的雾化颗粒可以具有从约5μm至约200μm的粒径。在另一个实施方式中,雾化颗粒可以具有从约20μm至约150μm的粒径。当所述雾化消毒剂包含胶体过渡金属时,雾化颗粒一般具有充分的大小,以包含至少一个胶体过渡金属,尽管一般地,各雾化颗粒会包含多个胶体过渡金属颗粒。
雾化通常是完整生物安全程序的最后阶段,并且如此,可在疾病预防和控制中扮演主要的角色。传统的雾化剂例如甲醛、戊二醛、或戊二醛可以给接触到消毒剂的人造成较多的健康和安全问题。因为本发明的消毒剂可以被配制成仅使用食品级成分,因此它们在消毒剂雾化中的应用具有大的价值。大多数制雾机通过在大的压力下使用高容量的空气来产生小滴而工作。本发明的消毒剂组合物与大多数标准制雾机相容。合适的制雾机的例子包括Thermal Foggers和Cold Foggers。
作为溶液,所述组合物可被用作诸如仪器的物体的液体分散浴或者用作应用于较少移动的物体的喷雾剂。所述消毒剂溶液还可以用作局部敷料或嗽口水。换句话说,根据本发明的实施方式,可以利用本领域普通技术人员已知的任何应用方法。
可以通过许多方法的任何一种制备本发明的消毒剂组合物而进行应用。例如,所述组合物可以制备为溶液、凝胶、泡沫、喷雾等等。作为溶液,所述组合物可被用作浸渍仪器或其它物体的液体分散浴、用作用于较少移动的物体的喷雾剂、用作其中液体分散液被施用于织物或织物样材料以容易应用而无需喷雾或其它应用方法的擦抹布、用作局部敷料、用作嗽口水等等。换句话说,根据本发明的实施方式,可以利用本领域普通技术人员已知的任何应用方法。
另外,尽管本发明的组合物通常被描述为消毒剂、杀菌剂或卫生洗涤剂,但认识到存在许多可能的应用。例如,非限制性地,本发明的组合物可用于杀死细菌、孢子、病毒、寄生虫、真菌和霉菌。如所述,该组合物可在对人和其它哺乳动物完全安全的情况下被用于抗所有这些类型的生物体。
因为这些组合物可以被配制得很安全,例如,通常仅包括食品级组分,所以这些组合物可被用于远远超出它们作为硬表面消毒剂的领域。这样的产品种类包括用于人和动物的外部和内部施用的产品。例如,这些组合物可被用于防腐剂、烧伤治疗、尿疹产品和各种护肤产品。可选地,这些组合物可被用于口腔内部,例如嗽口水、牙膏和应用于牙模材料的各种其它消毒溶液。因为已知牙模传播牙工业中的重要疾病,这类牙模应用可预防或降低病原体从患者口腔传播到用成品模工作的实验室雇员。此外,进一步的有用种类包括抗生素和抗病毒目的的应用。这些组合物可以配制成锭剂或胶,用于口腔和咽喉,并且甚至可以经口、肌内、静脉内等加以施用。由于可实现的杀死水平,即使当仅用食品级组分配制时,各种各样的病原体以及一些病毒也可在内部杀死。不受限于任何具体的可能性,这些组合物可用于杀死各种病毒,例如HIV、SARS、西尼罗病毒、禽流感病毒、及其它病毒。
实施例
下列实施例阐述了目前最熟知的本发明的实施方式。然而,可以理解,下列仅仅是示例性的或说明性的本发明原理的应用。本领域普通技术人员可以设计许多的改变和可选的组合物、方法和系统而不背离本发明的精神和范围。所附权利要求旨在覆盖这样的改变和安排。因此,尽管本发明已经在上文进行了详细描述,但下列实施例进一步提供与什么是目前视为本发明最实际的和优选的实施方式有关的细节。
实施例1-消毒剂的制备
根据本发明的实施方式,制备水性消毒剂组合物,其包括下列近似量的成分:9wt%乙醇;1.3wt%过乙酸(来自6wt%溶液);稳定所述过乙酸的3wt%以下的过氧化氢;和余量的包含600ppm胶体银的水。注意,当基于水性载体总体含量时,存在按重量计600ppm以下的胶体银。
实施例2-消毒剂的制备
根据本发明的实施方式,制备水性消毒剂组合物,其包括下列近似量的成分:9wt%异丙醇;1.3wt%过丙酸(来自6wt%溶液);稳定所述过丙酸的3wt%以下的过氧化物例如过氧化钠;和余量的包含600ppm离子银的水。注意,当基于水性载体总体含量时,存在按重量计600ppm以下的离子银。
实施例3-消毒剂的制备
根据本发明的实施方式,制备水性消毒剂组合物,其包括下列近似量的成分:20wt%变性酒精;5wt%过甲酸;和余量的包含按重量计10,000ppm胶体银和铜合金的水。小量的过氧化氢和甲酸也整体加入所述组合物以稳定过甲酸。注意,当基于水性载体总体含量时,存在按重量计10,000ppm以下的胶体银。
实施例4-消毒剂的制备
根据本发明的实施方式,制备水性消毒剂组合物,其包括下列近似量的成分:9wt%乙醇;1.3wt%过乙酸(来自6wt%溶液);稳定所述过乙酸的3wt%以下的过氧化氢;和余量的包含80ppm胶体银的水。注意,当基于水性载体总体含量时,存在按重量计80ppm以下的胶体银。
实施例5-消毒剂的制备
根据本发明的实施方式制备消毒剂组合物,其包括下列近似量的成分:10wt%丙三醇;1.3wt%过乙酸;和余量的具有大约300ppm胶体银的水。注意,当基于水性载体总体含量时,存在按重量计300ppm以下的胶体银。
实施例6-消毒剂的制备
根据本发明的实施方式制备消毒剂组合物,其包括下列近似量的成分:10.0wt%丙三醇;1.8wt%过柠檬酸;和余量的具有大约300ppm胶体银的水。注意,当基于水性载体总体含量时,存在按重量计300ppm以下的胶体银。
实施例7-消毒剂的制备
根据本发明的实施方式制备消毒剂组合物,其包括下列近似量的成分:8.5wt%1-丙醇;1.3wt%过乙酸;和余量的包含按重量计约300ppm胶体银的RO水(反渗透水)。注意,当基于水性载体总体含量时,存在按重量计300ppm以下的胶体银。
实施例8-消毒剂的制备
根据本发明的实施方式制备消毒剂组合物,其包括下列近似量的成分:40wt%丙三醇;8wt%过柠檬酸;和余量的包含按重量计约300ppm胶体银的RO水(反渗透水)。注意,当基于水性载体总体含量时,存在按重量计300ppm以下的胶体银。
实施例9-消毒剂的制备
根据本发明的实施方式制备消毒剂组合物,其包括下列近似量的成分:8.5wt%丙三醇;0.4wt%过乙酸;和余量的包含按重量计300ppm胶体银的RO水(反渗透水)。注意,当基于水性载体总体含量时,存在按重量计300ppm以下的胶体银。
实施例10-使用实施例1的消毒剂进行金黄色葡萄球菌(Staphylococcus aureus)的杀死时间研究
进行研究,以在用有机负荷(organic load)激发测试生物体金黄色葡萄球菌时,测量实施例1的含胶体银消毒剂的抗微生物活性。这通过对含5%v/v马血清的消毒剂进行标准悬浮液测试而实现。评估15秒接触时间。
具体地,通过在Todd Hewitt Broth中在37℃生长5ml金黄色葡萄球菌ATCC 6538培养物20小时,制备测试悬浮液。通过离心沉淀五(5)ml培养物,用5ml无菌18MΩ水洗涤,再次离心,并重悬于终容积5ml的无菌水中。
制备由9ml管的12.7wt%Tween 80(表面活性剂)、6.0wt%Tamol、1.7wt%卵磷脂、1wt%蛋白胨和0.1wt%胱氨酸组成的中和剂,向其加入10pd的过氧化氢酶溶液(Sigma,C100,42,300单位/mg)。
遵循的“杀死时间”程序如下:9.9ml等分试样的实施例1的消毒剂(包含5%v/v马血清)被置于无菌20mm×150mm管,并且该管在20℃水浴中平衡。该消毒剂管在时间零时用100μl测试生物体悬浮液接种。在15秒之后,1ml的该生物体/消毒剂悬浮液被移到9ml的中和剂中。在2分钟之后,该中和的悬浮液在生理盐水溶液(PSS)中进行连续稀释(1:1×10、1:1×102、1:1×103等)。在所选的稀释管中存活的生物体的数目通过膜过滤进行测定。一(1)ml等分试样一式两份进行铺板,并且膜用约100ml的无菌PSS洗涤,并移至Columbia琼脂板。板在37℃接种20小时。对在每个过滤器上菌落的数目进行计数,并计算对数减少值和杀死百分比值。
作为对照,通过进行测试悬浮液在PSS中的所选择1:10稀释液的膜过滤测定,计算测试悬浮液的滴定度(或者物质在溶液中的量或浓度的量度)。通过用100μl的该滴定度的1:105稀释液接种9ml的中和剂和1ml的消毒剂的混合物,进行中和剂对照。这在该管中产生约1,500CFU/ml,其允许在稀释并使用相同的1ml样品通过膜过滤进行该管的测定之前静置20分钟。通过过滤该测试中使用的每个溶液的100ml(PSS)或1ml(其它液体)样品,进行灭菌对照。如上对板进行接种。
结果提供如下:
表1a-滴定度
*TNC–太多而无法计数
表1b-消毒剂溶液(含5%v/v马血清的实施例1溶液)葡萄球菌/消毒剂悬浮液的稀释
表1c–中和对照
灭菌对照表明中和剂、水、PSS、Columbia琼脂、消毒剂和马血清的零增长。滴定度结果示出了在原始悬浮液中每ml 1×l010个生物体的存活葡萄球菌浓度。用100μl该悬浮液接种9.9ml的消毒剂在该测定管中产生了每ml 1×l08个生物体的初始浓度。这些步骤的结果允许使用下式计算对数减少(LR)值和杀死百分比(PK)值:1)LR=-Log(S/So),其中S=45分钟后存活生物体的浓度;而So=在时间零时存活生物体的初始浓度;和2)PK=(1-(S/So))×100。这些值在下面示出。
表2–结果
中和对照数据表明,测试溶液得到充分中和。观察到的计数稍大于期望的计数,表明无未中和的消毒剂导致发生残余杀灭。一般而言,这里测试的消毒剂溶液对金黄色葡萄球菌具有高的抗微生物活性。重要的是注意,即使消毒剂与由5%v/v马血清组成的有机荷载预混合,也实现该水平的活性。有机荷载(例如5%v/v马血清)常常不利地影响消毒剂的抗微生物作用。然而,即使在存在5%v/v马血清的情况下,实施例1的溶液能够在15秒内实现7以上的存活生物体对数减少。
实施例11-使用实施例6的消毒剂进行枯草杆菌(Bacillus subtilis)的杀死时间研究
对来自测试生物体枯草杆菌的细菌内生孢子进行测定实施例6的含胶体银消毒剂的抗微生物活性的研究。这通过使用枯草杆菌内生孢子悬浮液进行标准杀死时间悬浮试验而实现。
具体地,从在Leighton-Doi培养基中在37℃生长3天的培养物,制备包含来自枯草杆菌的内生孢子的测试悬浮液。将该悬浮液置于65℃30分钟,以杀死营养型生物体,然后离心以沉淀孢子。将孢子重悬于无菌HPLC水,并在4℃放置过夜。重复该洗涤/放置过程,总共三次。使用相差显微镜检查最终孢子悬浮液的纯度,并将其在4℃储存,直到使用。
制备由9ml管的12.7wt%Tween 80(表面活性剂)、6.0wt%Tamol、1.7wt%卵磷脂、1wt%蛋白胨、1.0wt%胱氨酸和500mM Tris(pH 7.85)组成的中和剂,在使用前即刻向其加入100μl的过氧化氢酶溶液(Sigma C100,42,300/mg)。
遵循的“杀死时间”程序如下:9.9ml等分试样的实施例6的消毒剂(包含5%v/v马血清)被置于无菌50ml聚丙烯离心管,并且该管在20℃水浴中平衡。该消毒剂管在时间零用100μl孢子/消毒剂悬浮液接种。在60秒之后,1ml的该孢子/消毒剂悬浮液被移至9.1ml的中和剂中。在2分钟之后,该中和的悬浮液在生理盐水溶液(PSS)中进行连续稀释(1:1×10、1:1×102、1:1×103等)。在所选的稀释管中存活孢子的数目通过膜过滤进行测定。一(1)ml等分试样一式两份进行铺板,并且膜用约100ml的无菌PSS洗涤,并移至Columbia琼脂板。板在37℃接种20小时。对在每个过滤器上菌落的数目进行计数,并计算对数减少值和杀死百分比值。
作为对照,通过进行测试悬浮液在PSS中的所选择1:10稀释液的膜过滤测定,计算测试悬浮液的滴定度(或者物质在溶液中的量或浓度的量度)。通过用100μl的该滴定度的1:106稀释液接种9.1ml的中和剂和1ml的消毒剂的混合物,进行中和剂对照。这在该管中产生约96CFU/ml,其允许在稀释并使用同样的1ml样品通过膜过滤进行该管的测定之前静置20分钟。通过过滤该测试中使用的每个溶液的100ml(PSS)或1ml(其它液体)样品,进行灭菌对照。如上对板进行接种。
结果提供如下:
表15a-滴定度
*TNC–太多而无法计数
表15b-消毒剂溶液(实施例6溶液)枯草杆菌孢子/消毒剂悬浮液的稀释
表15c–消毒剂溶液(实施例6)枯草杆菌孢子/消毒剂悬浮液的稀释
表15d–中和对照
表15e-无菌对照
材料 | 计数 |
实施例6消毒剂 | 0 |
中和剂 | 0 |
Columbia琼脂 | 0 |
生理无菌盐水 | 0 |
滴定度结果示出了在原始悬浮液中每ml 9.80×l09个孢子的存活枯草杆菌孢子浓度。用100μl该悬浮液接种9.9ml的消毒剂在该测定管中产生了每ml 9.80×l07个孢子的初始浓度。这些步骤的结果允许使用下式计算对数减少(LR)值和杀死百分比(PK)值:1)LR=-Log(S/So),其中S=45分钟后存活生物体的浓度;而So=在时间零时存活生物体的初始浓度;和2)PK=(1-(S/So))×100。这些值在下面示出。
表16-结果
中和对照数据表明,测试溶液得到充分中和。观察到的计数类似于或大于期望的计数,表明无未中和的消毒剂导致发生残余杀灭。实施例6的消毒剂溶液具有良好的杀孢子活性,在3分钟内实现1.38的对数减少并且在10分钟内实现7的对数减少。值得注意的是,枯草杆菌是在杀孢子测试中使用的常见物种,并且与导致炭疽的生物体属于同一属。因为它们的相似性,枯草杆菌孢子已经被用作炭疽杆菌(Bacillus anthracis)的孢子的非致病性替代物。
实施例12-使用实施例5的消毒剂溶液进行牛分枝杆菌(Mycobacterium bovis)的杀死时间研究
使用CRA环境擦拭法(CRA Environmental Wipe Method),在硬表面上进行测定实施例5的消毒剂溶液的杀结核菌活性的研究。该方法完整描述于:Christensen,R.P.,R.A.Robison,D.F.Robinson,B.J.Ploeger,R.W.Leavitt和H.L.bodily,Antimicrobial Activity ofEnvironmental Surface Disinfecants in the Absence and Presence ofBioburden.Journal of the American Dental Association,119:493-505.1989.
具体地,从在改性Proskauer-Beck培养基中培养的标准化培养物的冷冻悬浮液,制备包含牛分枝杆菌(ATCC#35743)的测试悬浮液。解冻所述悬浮液,并使之与等体积的磷酸盐缓冲明胶溶液在玻璃载特氟隆组织磨碎器中在冰上进行混合。匀化悬浮液两分钟,然后在包含0.1%Tween 80的生理盐水溶液(PSS)中以1:4进行稀释。涡旋所述悬浮液并且保持在冰上直到用于接种测试表面。中和剂混合物由50ml瓶的含有1.0%Tween 80的胰胨豆胨培养液(Tryptic soy broth)、1.0%卵磷脂和50μl的浓过氧化氢酶溶液(Sigma,C100,42,300单位/mg)组成。
使用的CRA环境擦拭法在下面详述。一片8×12英寸的层压塑料计数器盖用有机硅粘合剂固定于聚丙烯牙科托盘(B尺寸,Zirc Dental)。通过过氧化氢气体等离子体消毒器对盖子和托盘进行灭菌。用无菌的充填2×2英寸棉花的纱布海绵,将2ml测试生物体悬浮液施加于表面。使表面在层流下、在生物安全的柜中干燥20-30分钟。然后,3.5ml的消毒剂(或水)被施加于无菌纱布海绵,其被用于使用约150-g压力,采用重叠行程(20次从左到右,随后20次从上到下)擦拭接种的测试表面10秒。在3分钟之后,使托盘充满50ml的中和剂并且用无菌聚丙烯刷子刷1分钟,以除去并悬浮生物体。收集液体,并在生理盐水溶液(PSS)中以1:10进行连续稀释。在所选的稀释管中存活生物体的数目通过膜过滤进行测定。一毫升等分试样一式两份进行铺板。膜用约100ml的无菌PSS洗涤,并移至分枝杆菌7H11琼脂板。板在37℃接种约三周。对在每个过滤器上菌落的数目进行计数,并计算对数减少值和杀死百分比值。
作为对照,通过进行测试悬浮液在PSS中的所选择1:10稀释液的膜过滤测定,计算测试悬浮液的滴定度。通过用100μl的含1750CFU的滴定度的1:103稀释液接种9ml的中和剂和1ml的消毒剂的混合物,进行中和剂对照。这在该管中产生约175CFU/ml,其允许在稀释并使用重复的1ml样品通过膜过滤进行该管的测定之前静置20分钟。
结果提供如下:
表19a–牛分枝杆菌滴定度
*TNC–太多而无法计数
表19b-实施例5的消毒剂溶液牛分枝杆菌/消毒剂悬浮液的稀释
表19c–中和对照
表19d–无菌对照
滴定度结果表明,在所制备的悬浮液中,牛分枝杆菌的初始浓度为每ml 1.75×107CFU。接种所述测试表面,随后进行干燥,这产生了水对照表现出的攻击。测试表面上存活杆菌的初始浓度(So)为2.63×105。这些步骤的结果允许使用下式计算对数减少(LR)值和杀死百分比(PK)值:1)LR=-Log(S/So),其中S=在暴露于消毒剂一段时间后存活生物体的浓度;而So=在时间零下存活生物体的初始浓度;这些值在下面表20示出。
表20-结果
溶液 | 接触时间 | 对数减少(LR) | 杀死百分比(PK) |
实施例5 | 3分钟 | 5.02 | 99.99905 |
中和对照数据表明,各测试溶液得到充分中和。观察到的计数类似于从滴定度数据期望的计数。
实施例13-使用各种消毒剂溶液进行杀孢子活性的杀死时间研究
对来自测试生物体枯草杆菌的细菌内生孢子进行测定实施例5的含银消毒剂的抗微生物活性的研究。这通过使用枯草杆菌内生孢子悬浮液进行标准杀死时间悬浮试验而实现。一般而言,孢子比一般的细菌更难以杀死。
从在Leighton-Doi培养基中在37℃生长3天的培养物,制备包含来自枯草杆菌(ATCC#19659)的内生孢子的测试悬浮液。将该悬浮液置于65℃30分钟,以杀死营养型生物体,然后离心以沉淀孢子。将孢子重悬于无菌HPLC水,并在4℃放置过夜。重复该洗涤/放置过程,总共三次。使用相差显微镜检查最终孢子悬浮液的纯度,并将其在4℃储存,直到使用。
也制备由9ml管的12.7wt%Tween 80、6.0wt%Tamol、1.7wt%卵磷脂、1wt%蛋白胨、1.0wt%胱氨酸和500mM Tris(pH 7.85)组成的中和剂溶液,在使用前即刻向其加入100μl的过氧化氢酶溶液(SigmaC100,42,300/mg)。
遵循的“杀死时间”程序如下:9.9ml等分试样的消毒剂被置于50ml聚丙烯无菌离心管。该管在20℃水浴中平衡。该消毒剂管在时间零下用100μl孢子悬浮液接种。在30秒接触时间之后,1ml的孢子/消毒剂悬浮液被移至9.1ml中和剂。彻底混合该管。在2分钟之后,该中和的悬浮液在生理盐水溶液(PSS)中以1:10进行连续稀释。在所选的稀释管中存活孢子的数目通过膜过滤进行测定。一(1)ml等分试样一式两份进行铺板。膜用约100ml的无菌PSS洗涤,并移至Columbia琼脂板。板在37℃接种20小时。对在每个过滤器上菌落的数目进行计数,并计算对数减少值和杀死百分比值。
作为对照,通过进行测试悬浮液在PSS中的所选择1:10稀释液的膜过滤测定,计算测试悬浮液的滴定度。通过用100μl的该滴定度的1:106稀释液接种9.1ml的中和剂和1ml的消毒剂的混合物,进行中和剂对照。这在该管中产生约130CFU/ml,其允许在稀释并使用同样的1ml样品通过膜过滤进行该管的测定之前静置20分钟。
结果提供如下:
表23a–枯草杆菌滴定度
*TNC–太多而无法计数
表23b-消毒剂溶液(实施例5)枯草杆菌孢子/消毒剂悬浮液的稀释
表23c–中和对照
表23d–无菌对照
材料 | 计数 | 材料 | 计数 |
PSS | 0 | 实施例5 | 0 |
中和剂 | 0 | 实施例7 | 0 |
Columbia琼脂 | 0 | ----- | ----- |
滴定度结果示出了在原始悬浮液中每ml 1.11×1010个孢子的存活枯草杆菌孢子浓度。用100μl该悬浮液接种9.9ml的消毒剂在该测定管中产生了每ml 1.11×l08个孢子的初始浓度。这些步骤的结果允许使用下式计算对数减少(LR)值和杀死百分比(PK)值:1)LR=-Log(S/So),其中S=在指定接触时间后存活生物体的浓度;而So=在时间零下存活生物体的初始浓度;和2)PK=(1-(S/So))×100。这些值在下面示出。
表24-结果
溶液 | 接触时间 | 对数减少(LR) | 杀死百分比(PK) |
实施例5 | 30秒 | >7.05 | >99.999991 |
实施例7 | 30秒 | >7.05 | >99.999991 |
中和对照数据揭示,测试溶液能够充分中和该消毒剂。观察到的计数始终高于期望的计数。每种测试消毒剂溶液(实施例5和7)具有快速和有效的杀孢子活性。具体而言,实施例5和7的每一种能在30秒内达到7的对数减少。作为对照,使用相同浓度的不具有任何其它活性成分(即不具有醇或银含量)的过乙酸来测试同一培养物。实施例5和7的组合物表现出高出若干数量级的杀死水平。
实施例14–使用2.4%碱性戊二醛消毒剂进行杀孢子活性的杀死时间研究
为了比较的目的,对来自测试生物体枯草杆菌的细菌内生孢子进行测定2.4%碱性戊二醛消毒剂的抗微生物活性的研究。戊二醛消毒液是医院中使用的常见消毒剂,以杀死细菌和其它否则可能难以杀死的病原体。通过使用枯草杆菌内生孢子悬浮液进行标准杀死时间悬浮试验来进行该研究。评价15分钟接触时间。
从在营养琼脂上生长的培养物制备包含来自枯草杆菌(ATCC#19659)的内生孢子的测试悬浮液,其中向所述营养琼脂加入额外的孢子形成增强剂。用无菌水收集板,并通过重复离心和重悬于水来纯化内生孢子。最终的洗涤在70wt%乙醇中进行30分钟,以确保所有营养型细菌死亡。孢子被重悬于含有0.1wt%Tween 80的水中以防止凝集,并将其在4℃储存,直到使用。
制备由1ml新制备的过滤灭菌的5.28wt%亚硫酸氢钠溶液组成的中和剂。
遵循的“杀死时间”程序如下:9.9ml等分试样的消毒剂被置于无菌玻璃培养管中。该管在20℃水浴中平衡。该消毒剂管——9ml的2.4wt%碱性戊二醛(新活化的CIDEXPLUS,3.4%,Lot#:2002247TP–用无菌水稀释至2.4wt%),在时间零下用100μl测试生物体悬浮液接种。在15分钟之后,1ml的孢子/消毒剂悬浮液被移至9.1ml的中和剂。彻底混合该管。在2分钟之后,该中和的悬浮液在生理盐水溶液(PSS)中进行连续稀释(1:1×10、1:1×102、1:1×103等)。在所选的稀释管中存活孢子的数目通过膜过滤进行测定。一(1)ml等分试样一式两份进行铺板。膜用约100ml的无菌PSS洗涤,并移至Columbia琼脂板。板在37℃接种20小时。对在每个过滤器上菌落的数目进行计数,并计算对数减少值和杀死百分比值。
作为对照,通过进行测试悬浮液在PSS中的所选择1:10稀释液的膜过滤测定,计算测试悬浮液的滴定度。
通过用100μl的该滴定度的1:105稀释液接种1ml的中和剂和1ml的消毒剂的混合物,进行中和剂对照。这在该管中产生约450CFU/ml,其允许在稀释并使用同样的1ml样品通过膜过滤进行该管的测定之前静置20分钟。
结果提供如下:
表27a-滴定度
*TNC–太多而无法计数
表27b-消毒剂溶液(2.4wt%碱性戊二醛消毒剂)枯草杆菌孢子/消毒剂悬浮液的稀释
表27C–中和对照
灭菌对照表明戊二醛、亚硫酸氢钠、水、PSS和Columbia琼脂的零生长。滴定度结果示出了在原始悬浮液中每ml 9.45×108个孢子的存活枯草杆菌孢子浓度。用100μl该悬浮液接种9.9ml的消毒剂在该测定管中产生了每ml 9.45×106个孢子的初始浓度。这些步骤的结果允许使用下式计算对数减少(LR)值和杀死百分比(PK)值:1)LR=-Log(S/So),其中S=1小时后存活生物体的浓度;而So=在时间零下存活生物体的初始浓度;和2)PK=(1-(S/So))×100。这些值在下面表28示出。
表28-结果
溶液 | 接触时间 | 对数减少(LR) | 杀死百分比(PK) |
碱性戊二醛 | 15min | 0.48 | 67.1 |
中和对照数据揭示,测试溶液能够充分中和该消毒剂。观察到的计数高于期望的计数。所测试的2.4wt%碱性戊二醛溶液具有相对慢的杀孢子活性,在15分钟内仅仅产生0.48的对数减少,这显著低于根据本发明的实施方式制备的上述示例性组合物的任一种达到的对数减少。
实施例15-使用喷雾剂进行分枝杆菌的杀死时间研究
为了比较的目的,使用CRA环境擦拭法(CRA Environmental WipeMethod),在硬表面上进行测定喷雾消毒剂(Lysol Spray,springwaterfall scent Lot#B4194-NJ21413-A3)的杀结核菌活性的研究。该方法完整描述于:Christensen,R.P.,R.A.Robison,D.F.Robinson,B.J.Ploeger,R.W.Leavitt,和H.L.bodily,Antimicrobial Activity ofEnvironmental Surface Disinfecants in the Absence and Presence ofBioburden.Journal of the American Dental Association,119:493-505,1989。
具体地,从在改性Proskauer-Beck培养基中培养的标准化培养物的冷冻悬浮液制备包含牛分枝杆菌(ATCC#35743)的测试悬浮液。解冻所述悬浮液,并使之与等体积的磷酸盐缓冲明胶溶液在玻璃载特氟隆(Teflon-on-glass)组织磨碎器中在冰上进行混合。匀化悬浮液两分钟,然后在包含0.1%Tween 80的生理盐水溶液(PSS)中以1:4进行稀释。涡旋所述悬浮液并且保持在冰上,直到用于接种测试表面。中和剂混合物由50ml瓶的含有1.0%Tween 80的胰胨豆胨培养液、1.0%卵磷脂和50μl的浓过氧化氢酶溶液(Sigma,C100,42,300单位/mg)组成。
使用的CRA环境擦拭法在下面详述。一片8×12英寸的层压塑料计数器盖用有机硅粘合剂固定于聚丙烯牙科托盘(B尺寸,Zirc Dental)。通过过氧化氢气体等离子体消毒器对盖子和托盘进行灭菌。用无菌的充填2×2英寸棉花的纱布海绵,将2ml测试生物体悬浮液施加于表面。使表面在层流下、在生物安全的柜中干燥20-30分钟。然后,3.5ml的消毒剂(或水)被施加于无菌纱布海绵,其被用于使用约150-g压力,采用重叠行程(20次从左到右,随后20次从上到下)擦拭接种测试表面10秒。在3分钟之后,使托盘充满50ml的中和剂并且用无菌聚丙烯刷子刷1分钟,以除去并悬浮生物体。收集液体,并在生理盐水溶液(PSS)中以1:10进行连续稀释。在所选的稀释管中存活生物体的数目通过膜过滤进行测定。一毫升等分试样一式两份进行铺板。膜用约100ml的无菌PSS洗涤,并移至分枝杆菌7H11琼脂板。板在37℃接种约三周。对在每个过滤器上菌落的数目进行计数,并计算对数减少值和杀死百分比值。
作为对照,通过进行测试悬浮液在PSS中的所选择1:10稀释液的膜过滤测定,计算测试悬浮液的滴定度。通过用100μl的含1750CFU的滴定度的1:103稀释液接种9ml的中和剂和1ml的消毒剂的混合物,进行中和剂对照。这在该管中产生约175CFU/ml,其允许在稀释并使用相同的1ml样品通过膜过滤进行该管的测定之前静置20分钟。
结果提供如下:
表17a-滴定度
*TNC–太多而无法计数
表173b-消毒剂溶液(喷雾剂)牛分枝杆菌/消毒剂悬浮液的稀释
表17c–中和对照
表17d–无菌对照
滴定度结果表明,在所制备的悬浮液中,牛分枝杆菌的初始浓度为每ml 1.75×107CFU。接种所述测试表面,随后进行干燥,这产生了水对照表现出的攻击。测试表面上存活杆菌的初始浓度(So)为2.63×105。这些步骤的结果允许使用下式计算对数减少(LR)值和杀死百分比(PK)值:1)LR=-Log(S/So),其中S=在暴露于消毒剂一段时间后存活生物体的浓度;而So=在时间零下存活生物体的初始浓度;这些值在下面表18示出。
表18-结果
中和对照数据表明,各测试溶液得到充分中和。观察到的计数类似于从滴定度数据期望的计数。
实施例16–使用某些合金提高杀死率
为证明某些合金在提高枯草杆菌的杀死率中的效果,制备这样的组合物,其包含按重量计0.5%的过氧化氢、按重量计8%的乙醇以及余量的含有300ppm胶体银的水。使用相同的组分制备类似的组合物,只是水溶液包含与锰混合的银合金(约300ppm银和约7ppm锰)。使用胶体银组合物,进行杀死测试,在30秒后得到枯草杆菌0.13的对数减少或25.6%的杀死率。也使用胶体银-锰合金组合物进行该杀死研究,其在30秒后得到0.24的对数减少或42.6%的杀死率。
实施例17–消毒嗽口水
使用实施例1至9的任一个中描述的消毒剂组合物制造消毒嗽口水(口腔清洗剂)。所述嗽口水通过混合消毒剂组合物与山梨糖醇(增甜剂)、其量足以提供250ppm的氟离子的氟化钠(氟离子组分)和薄荷油(调味剂)进行制备。所述成分与通过用水以按重量计约1:10稀释的实施例之一的消毒剂组合物混合。注意,通过用水以按重量计1:10稀释总组合物,胶体银含量显著降低。如果期望具有较高的胶体银重量百分数,则银含量可以配制至比实施例1至9中的含量更高,以便当稀释嗽口水时,较高的银含量存在于溶液中。
实施例18–消毒牙膏
使用实施例1至9的一个中的消毒剂组合物制造消毒牙膏。所述牙膏通过混合消毒剂组合物与水、水合氧化硅、山梨糖醇、甘油、十二烷基硫酸钠、二氧化钛、薄荷醇、三磷酸五钠和PEG-6进行制备。所述成分以足以产生具有消毒性质的膏的量混合在一起。此外,注意,通过稀释具有膏形成成分和其它成分的总组合物,离子银含量显著降低。如果期望具有较高重量百分数的银,则银含量可以配制至比上文组合物实施例中的含量更高,以便当配制牙膏时,较高的银含量存在于牙膏中。
实施例19–消毒软膏
使用实施例1至9之一的消毒剂溶液制备消毒软膏。该消毒剂与芦荟凝胶混合,形成消毒软膏。然后,该凝胶被施用于对象皮肤上的感染。该消毒软膏消毒了所述皮肤,并对对所述感染的刺激提供了某些减轻。
实施例20–消毒肥皂或洗发剂
使用实施例1至9之一的消毒剂溶液制备消毒液体皂。消毒剂与水、月桂基醚硫酸钠、十二烷基硫酸钠、硫酸钠、椰油酰胺丙基甜菜碱、柠檬酸、氯化钠、香料、DMDM乙内酰脲和EDTA四钠混合,产生消毒液体皂或洗发剂。所述肥皂或洗发剂具有粘性,使其容易使用传统的泵分配器进行分配。通过使用所述消毒剂作为用于肥皂形成方法的成分之一,可同样地制备手用硬肥皂。
实施例21–消毒擦抹布
使用实施例1至9之一的消毒剂溶液制备消毒擦抹布。非织造棉织物用所述消毒溶液浸渍。通过将层叠棉织物片置于容器中,用消毒剂溶液浸透所述织物片,以及将盖置于所述容器上并密封所述容器以防止所述消毒剂溶液蒸发,制造擦抹布。如果消毒剂溶液包括胶体金属,则小心确保每一和各个片非织造棉织物不仅暴露于液体,而且还暴露于固体颗粒。
实施例22–消毒凝胶
使用实施例1至9之一的消毒剂溶液制备消毒凝胶。该消毒剂与芦荟凝胶混合,形成消毒凝胶。所述凝胶被施用于对象皮肤上的感染。该消毒凝胶消毒了所述皮肤,并对所述感染的刺激提供某些减轻。
实施例23–消毒气溶胶和/或喷雾剂
实施例1至9之一的消毒剂组合物被用于形成消毒雾。使用来自的热喷雾机,在需要消毒的房间例如医院房间内将所述消毒剂组合物气溶胶化成小滴。使得消毒雾充满房间。该消毒雾对房间内的空气和硬表面进行杀菌和消毒。在大约40分钟的时间之后,气溶胶化颗粒基本上从空气沉降出,而所述房间基本得到消毒。
虽然本发明已经参考某些优选实施方式进行了描述,但本领域普通技术人员将理解,可进行各种改变、变化、省略和替换而不背离本发明的精神。因此,本发明仅意图受限于所附权利要求的范围。
Claims (10)
1.水性消毒剂组合物,其包含:
a)水性载体,其包括:
i)水;
ii)从0.001wt%至10.0wt%的过氧,所述过氧包括金属过氧化物;
iii)醇;和
b)基于所述水性载体的含量,按重量计从0.001ppm至50,000ppm的过渡金属或其合金。
2.权利要求1所述的组合物,其中所述金属过氧化物选自过氧化钠、过氧化镁、过氧化钙、过氧化钡和过氧化锶及其混合物。
3.水性消毒剂组合物,其包含:
a)水性载体,其包括:
i)水;
ii)从0.001wt%至10.0wt%的过氧,所述过氧包括过氧水合物;
iii)醇;和
b)基于所述水性载体的含量,按重量计从0.001ppm至50,000ppm的过渡金属或其合金。
4.水性消毒剂组合物,其包含:
a)水性载体,其包括:
i)水;
ii)从0.001wt%至10.0wt%的过氧,所述过氧包括原位产生的过氧化物;
iii)醇;和
b)基于所述水性载体的含量,按重量计从0.001ppm至50,000ppm的过渡金属或其合金。
5.权利要求4所述的组合物,其中所述原位产生的过氧化物是从过碳酸钠产生的过氧化氢。
6.水性消毒剂组合物,其包含:
a)水性载体,其包括:
i)水;
ii)从0.001wt%至10.0wt%的过氧,其中所述过氧包括过酸;和
iii)醇;
b)基于所述水性载体的含量,按重量计从0.001ppm至50,000ppm的胶体过渡金属或其合金。
7.权利要求6所述的组合物,其中所述消毒剂组合物基本上不含含氯和溴的组分。
8.权利要求6所述的组合物,其中所述消毒剂组合物基本上不含含碘递体的组分。
9.权利要求6所述的组合物,其中所述消毒剂组合物基本上不含含酚的组分。
10.权利要求6所述的组合物,其中所述消毒剂组合物基本上不含含季铵的组分。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/510,516 US7511007B2 (en) | 2005-02-25 | 2006-08-24 | Aqueous sanitizers, disinfectants, and/or sterilants with low peroxygen content |
US11/510,516 | 2006-08-24 | ||
CNA2007800356438A CN101516321A (zh) | 2006-08-24 | 2007-08-22 | 具有低过氧含量的水性卫生洗涤剂、消毒剂和/或杀菌剂 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007800356438A Division CN101516321A (zh) | 2006-08-24 | 2007-08-22 | 具有低过氧含量的水性卫生洗涤剂、消毒剂和/或杀菌剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104824019A true CN104824019A (zh) | 2015-08-12 |
Family
ID=39184090
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007800356438A Pending CN101516321A (zh) | 2006-08-24 | 2007-08-22 | 具有低过氧含量的水性卫生洗涤剂、消毒剂和/或杀菌剂 |
CN201510115387.XA Pending CN104824019A (zh) | 2006-08-24 | 2007-08-22 | 具有低过氧含量的水性卫生洗涤剂、消毒剂和/或杀菌剂 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007800356438A Pending CN101516321A (zh) | 2006-08-24 | 2007-08-22 | 具有低过氧含量的水性卫生洗涤剂、消毒剂和/或杀菌剂 |
Country Status (12)
Country | Link |
---|---|
US (1) | US7511007B2 (zh) |
EP (1) | EP2063852A4 (zh) |
JP (2) | JP5337032B2 (zh) |
KR (1) | KR101471684B1 (zh) |
CN (2) | CN101516321A (zh) |
AU (1) | AU2007295050B9 (zh) |
BR (1) | BRPI0716584A8 (zh) |
CA (1) | CA2661643A1 (zh) |
IL (1) | IL197207A0 (zh) |
MX (1) | MX2009002090A (zh) |
WO (1) | WO2008033206A1 (zh) |
ZA (1) | ZA200901673B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113365597A (zh) * | 2019-01-14 | 2021-09-07 | 多米尼卡·托姆帕麦杰森 | 含有活性氧化合物的制剂及其应用装置 |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006093792A1 (en) | 2005-02-25 | 2006-09-08 | Solutions Biomed, Llc | Aqueous disinfectants and sterilants |
US7462590B2 (en) * | 2005-02-25 | 2008-12-09 | Solutions Biomed, Llc | Aqueous disinfectants and sterilants comprising a peroxide/peracid/transition metal mixture |
US7504369B2 (en) | 2005-02-25 | 2009-03-17 | Solutions Biomed, Llc | Methods and compositions for decontaminating surfaces exposed to chemical and/or biological warfare compounds |
US7507701B2 (en) | 2005-02-25 | 2009-03-24 | Solutions Biomed, Llc | Aqueous disinfectants and sterilants including transition metals |
US7473675B2 (en) * | 2005-02-25 | 2009-01-06 | Solutions Biomed, Llc | Disinfectant systems and methods comprising a peracid, alcohol, and transition metal |
US7553805B2 (en) * | 2005-02-25 | 2009-06-30 | Solutions Biomed, Llc | Methods and compositions for treating viral, fungal, and bacterial infections |
US7534756B2 (en) * | 2005-02-25 | 2009-05-19 | Solutions Biomed, Llc | Devices, systems, and methods for dispensing disinfectant solutions comprising a peroxygen and transition metal |
KR100870277B1 (ko) | 2007-04-03 | 2008-11-25 | 김희빈 | 손과 발의 청결을 위한 젤의 조성물 |
ITPD20070242A1 (it) * | 2007-07-17 | 2009-01-18 | Farmogal S P A | Composizione conservante con argento elettrolitico per prodotti cosmetici |
WO2009032203A1 (en) * | 2007-08-30 | 2009-03-12 | Solutions Biomed, Llc | Colloidal metal-containing skin sanitizer |
US20090082472A1 (en) * | 2007-09-25 | 2009-03-26 | Peters Marlin W | Hand sanitizer and method of preparation |
US8464910B2 (en) * | 2008-03-14 | 2013-06-18 | Solutions Biomed, Llc | Multi-chamber container system for storing and mixing fluids |
US20100120913A1 (en) * | 2008-11-12 | 2010-05-13 | Larson Brian G | Resin catalyzed and stabilized peracid compositions and associated methods |
WO2010056881A1 (en) * | 2008-11-12 | 2010-05-20 | Solutions Biomed, Llc | Multi-chamber container system for storing and mixing liquids |
WO2010056871A2 (en) * | 2008-11-12 | 2010-05-20 | Solutions Biomed, Llc | Two-part disinfectant system and related methods |
WO2010080438A2 (en) * | 2008-12-18 | 2010-07-15 | Minntech Corporation | Sporicidal hand sanitizing lotion |
RU2553363C2 (ru) * | 2009-02-11 | 2015-06-10 | Рамот Ат Тель-Авив Юниверсити Лтд. | Антисептические композиции и их применения |
SE533902C2 (sv) | 2009-09-22 | 2011-02-22 | Small Particle Technology Gbg Ab | Nanopartiklar av silver |
US8778860B2 (en) * | 2009-10-14 | 2014-07-15 | S.C. Johnson & Son, Inc. | Green disinfection/sanitization compositions and processes of making thereof |
US8920850B2 (en) | 2010-06-02 | 2014-12-30 | Eco Product Group LLC | Antimicrobial colloidal silver products and method of making same |
DE102010026104B3 (de) | 2010-07-05 | 2011-12-01 | Fresenius Medical Care Deutschland Gmbh | Verfahren zur Sterilisation wenigstens eines Gegenstandes, Sterilisationsvorrichtung sowie Verwendung hierzu |
CN102369953B (zh) * | 2010-08-18 | 2014-03-19 | 赵含淳 | 一种环保杀菌、消毒、保鲜剂及其制法 |
JP2012056854A (ja) * | 2010-09-06 | 2012-03-22 | Neos Co Ltd | 抗菌剤組成物及び殺菌方法 |
RU2013134413A (ru) * | 2010-12-23 | 2015-01-27 | Франко Докманович ХАРРИС | Способ получения чистых зон с помощью противомикробных средств на основе коллоидного серебра и золота (варианты) |
JP6322355B2 (ja) * | 2011-01-28 | 2018-05-09 | 宣政 奥田 | 殺菌用洗浄組成物 |
US9327029B2 (en) * | 2011-05-05 | 2016-05-03 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
US10272108B2 (en) | 2011-05-05 | 2019-04-30 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
US8883848B2 (en) * | 2011-07-14 | 2014-11-11 | Ecolab Usa Inc. | Enhanced microbial peracid compositions and methods of use at reduced temperatures in aseptic cleaning |
AU2011247875B1 (en) * | 2011-09-16 | 2012-08-09 | Robert White | Disinfectant Compositions and Uses Thereof |
US20140030314A1 (en) * | 2012-01-13 | 2014-01-30 | Brian G. Larson | Treatment of skin disease |
AU2013359955B2 (en) | 2012-12-14 | 2017-08-10 | Saban Ventures Pty Limited | Synergistic disinfection enhancement |
US10206404B2 (en) | 2012-12-14 | 2019-02-19 | Saban Ventures Pty Limited | Disinfectant |
EP2905034B1 (fr) * | 2014-02-06 | 2024-05-01 | Maillefer Instruments Holding S.À.R.L. | Solution d'irrigation à nanoparticules pour utilisation dans une méthode de traitement endodontique. |
AU2015249841B2 (en) | 2014-04-21 | 2020-05-14 | Aclaris Therapeutics, Inc. | Peroxide formulations and methods and applicators for using the same |
US10750749B2 (en) | 2014-04-28 | 2020-08-25 | American Sterilizer Company | Process and composition for killing spores |
US10869479B2 (en) * | 2014-04-28 | 2020-12-22 | American Sterilizer Company | Wipe for killing spores |
US10463754B2 (en) | 2014-04-28 | 2019-11-05 | American Sterilizer Company | Process for decontaminating or sterilizing an article |
MX2017002916A (es) | 2014-09-09 | 2017-05-30 | Lonza Ag | Composicion de desinfectante que contiene compuestos de amonio cuaternario. |
CN105267060A (zh) * | 2015-11-20 | 2016-01-27 | 扬州中福生物技术有限公司 | 一种银基去屑洗发水及其制备方法 |
US10441115B2 (en) * | 2016-02-11 | 2019-10-15 | Gojo Industries, Inc. | High quality non-aerosol hand sanitizing foam |
US10912426B2 (en) | 2016-04-06 | 2021-02-09 | Gojo Industries, Inc. | Sequentially activated multi-diaphragm foam pumps, refill units and dispenser systems |
US11634860B2 (en) | 2016-05-12 | 2023-04-25 | Applied Silver, Inc. | Articles and methods for dispensing metal ions into laundry systems |
CN110113946A (zh) | 2016-10-31 | 2019-08-09 | 应用银股份有限公司 | 向分批式洗衣机和烘干机中分配金属离子 |
KR20190021556A (ko) | 2017-08-23 | 2019-03-06 | 주식회사 티더블유 | 은-시트르산 콜로이드를 포함하는 살균제 및 이의 제조 방법 |
CN116547050A (zh) * | 2020-02-04 | 2023-08-04 | 库普利昂公司 | 粘附有金属纳米颗粒附聚体的空气过滤介质、其形成及其用途 |
FI130898B1 (en) * | 2020-12-21 | 2024-05-16 | Forchem Oyj | A method of killing dormant forms of bacteria, reducing viability and/or preventing germination |
WO2023184296A1 (en) * | 2022-03-31 | 2023-10-05 | 3M Innovative Properties Company | Gel hand sanitizer and preparation method therefor |
CN115253144A (zh) * | 2022-08-09 | 2022-11-01 | 青岛嘉智生物技术有限公司 | 针对戊二醛类消毒剂的中和剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1353574A (zh) * | 1999-04-23 | 2002-06-12 | 迪戈尔国际有限公司 | 基于h2o2、酸和金属离子的消毒组合物 |
EP1382666A1 (en) * | 2002-06-21 | 2004-01-21 | Tevan B.V. | Aqueous disinfecting compositions with rapid bactericidal effect |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US583176A (en) * | 1897-05-25 | Thread-holder | ||
US734467A (en) | 1900-05-05 | 1903-07-21 | Hixson Adjustable Sieve Co | Adjustable chaffer or sieve. |
US716077A (en) | 1901-08-05 | 1902-12-16 | Thomas Morrin | Adjustable-handle socket. |
US2103999A (en) | 1936-05-25 | 1937-12-28 | Silver Oxide Products Company | Disinfective and antiseptic compound for the treatment of ulcers, sores, and the like |
US2304104A (en) | 1938-12-10 | 1942-12-08 | Du Pont | Therapeutical zinc peroxide |
US4021338A (en) | 1976-08-07 | 1977-05-03 | Wisconsin Alumni Research Foundation | Method for treating septic tank effluent seepage beds and the like |
FR2462425A1 (fr) | 1979-08-01 | 1981-02-13 | Air Liquide | Procede de fabrication de solutions diluees stables de peracides carboxyliques aliphatiques |
US4311598A (en) | 1979-09-04 | 1982-01-19 | Interox Chemicals Limited | Disinfection of aqueous media |
US4321255A (en) | 1980-09-04 | 1982-03-23 | International Flavors & Fragrances Inc. | Use of branched ketones in augmenting or enhancing the aroma or taste of foodstuffs, chewing gums, toothpastes or chewing tobacco |
US4414127A (en) | 1981-07-06 | 1983-11-08 | Syntex (U.S.A.) Inc. | Contact lens cleaning solutions |
GB8515079D0 (en) | 1985-06-14 | 1985-07-17 | Kellway Pharma | Contact lens cleaning & disinfection |
US4655975A (en) | 1986-01-27 | 1987-04-07 | The Dow Chemical Company | Solid chelating poly(carboxylate and/or sulfonate)peroxyhydrate bleaches |
CH673225A5 (zh) | 1986-04-22 | 1990-02-28 | Sanosil Ag | |
BR9000909A (pt) | 1990-02-23 | 1991-10-15 | Brasil Peroxidos | Processo para producao acelerada de solucoes equilibradas e estaveis de acido peracetico em baixas concentracoes |
GB9004080D0 (en) | 1990-02-23 | 1990-04-18 | Interox Chemicals Ltd | Solutions of peracids |
NZ240355A (en) | 1991-06-04 | 1994-09-27 | Ecolab Inc | Sanitising composition comprising sorbic and benzoic acids |
DE4123292C2 (de) | 1991-07-13 | 1996-01-25 | Hungerbach Chemotechnik Gmbh | Mundhygienemittel und Verwendung einer mit einem Silberkolloid stabilisierten Wasserstoffperoxid-Lösung in Mundhygienemitteln |
DE69231686T2 (de) | 1991-07-15 | 2001-08-30 | Minntech Corp | Stabiles, antikorrosives peressig-/peroxid-sterili-sationsmittel |
US5357636A (en) * | 1992-06-30 | 1994-10-25 | Dresdner Jr Karl P | Flexible protective medical gloves and methods for their use |
US6257253B1 (en) | 1994-04-19 | 2001-07-10 | Ecolab Inc. | Percarboxylic acid rinse method |
US6302968B1 (en) | 1994-04-19 | 2001-10-16 | Ecolab Inc. | Precarboxylic acid rinse method |
US5563132A (en) | 1994-06-21 | 1996-10-08 | Bodaness; Richard S. | Two-step cancer treatment method |
DE69521082T2 (de) | 1994-08-01 | 2002-03-07 | Maruwa Kck Co. Ltd., Joetsu | Metallisches bakterizides Mittel |
JP3121503B2 (ja) | 1994-10-18 | 2001-01-09 | レンゴー株式会社 | 抗菌剤 |
FR2728143A1 (fr) | 1994-12-16 | 1996-06-21 | Sodifra | Composition aqueuse a base de h2o2, acides et ag, procede de preparation et utilisation dans le domaine de la desinfection et/ou de l'hygiene |
DE69525526T2 (de) | 1995-03-27 | 2002-10-31 | The Procter & Gamble Company, Cincinnati | Flüssige aktivierte Bleichmittelzusammensetzungen |
WO1997000667A1 (en) | 1995-06-22 | 1997-01-09 | Minnesota Mining And Manufacturing Company | Stable hydroalcoholic compositions |
US20060240381A1 (en) | 1995-08-31 | 2006-10-26 | Biolase Technology, Inc. | Fluid conditioning system |
DE19620411A1 (de) | 1996-04-01 | 1997-10-02 | Henkel Kgaa | Übergangsmetallamminkomplexe als Aktivatoren für Persauerstoffverbindungen |
DE19640365A1 (de) | 1996-09-30 | 1998-04-02 | Basf Ag | Polymer-Wasserstoffperoxid-Komplexe |
DE19640364A1 (de) * | 1996-09-30 | 1998-04-02 | Basf Ag | Topische Mittel zur Prophylaxe oder Behandlung bakterieller Hautinfektionen |
US6436342B1 (en) | 1996-11-13 | 2002-08-20 | The Procter & Gamble Company | Sprayable disinfecting compositions and processes for disinfecting surfaces therewith |
US6114298A (en) | 1996-11-13 | 2000-09-05 | The Procter & Gamble Company | Hard surface cleaning and disinfecting compositions comprising essential oils |
TR199902148T2 (xx) | 1997-03-07 | 2000-04-21 | The Procter & Gamble Company | Metal a�artma maddesi kataliz�r� ve a�artma maddesi etkinle�tiricileri ve/veya organik perkarboksilik asitler i�eren a�artma bile�imleri. |
US6218351B1 (en) | 1998-03-06 | 2001-04-17 | The Procter & Gamble Compnay | Bleach compositions |
US5977403A (en) | 1997-08-04 | 1999-11-02 | Fmc Corporation | Method for the production of lower organic peracids |
CN1281333B (zh) | 1997-10-10 | 2010-06-02 | 纯生物科学公司 | 消毒剂及其制造方法 |
US6569353B1 (en) | 1998-06-11 | 2003-05-27 | Lynntech, Inc. | Reactive decontamination formulation |
IL125520A0 (en) * | 1998-07-27 | 1999-03-12 | Makhteshim Chem Works Ltd | Environmentally compatible processes and compositions and materials treated thereby |
US6027469A (en) | 1998-12-03 | 2000-02-22 | Johnson; Lee D. | Disinfecting system for hemodialysis apparatus |
US6242009B1 (en) | 1999-04-20 | 2001-06-05 | Kareem I. Batarseh | Microbicidal formulations and methods to control microorganisms |
WO2005000324A2 (en) | 2003-06-03 | 2005-01-06 | American Biotech Labs | Colloidal silver composition having antimicrobial properties |
US6214299B1 (en) | 1999-06-01 | 2001-04-10 | Robert J. Holladay | Apparatus and method for producing antimicrobial silver solution |
MXPA02002129A (es) | 1999-08-27 | 2002-09-18 | Procter & Gamble | Componentes de formulacion de accion rapida, composiciones y metodos para lavanderia que los emplean. |
US6368611B1 (en) | 1999-08-31 | 2002-04-09 | Sts Biopolymers, Inc. | Anti-infective covering for percutaneous and vascular access device and coating method |
US20060122082A1 (en) | 2000-02-17 | 2006-06-08 | Leonard Paul | Foam/spray producing compositions and dispensing system therefor |
US6540791B1 (en) | 2000-03-27 | 2003-04-01 | The Procter & Gamble Company | Stable alkaline hair bleaching compositions and method for use thereof |
US6379712B1 (en) | 2000-09-13 | 2002-04-30 | Globoasia, L.L.C. | Nanosilver-containing antibacterial and antifungal granules and methods for preparing and using the same |
DE10054248A1 (de) * | 2000-11-02 | 2002-05-08 | Inst Neue Mat Gemein Gmbh | Mikrobizid beschichteter Gegenstand, Verfahren zu dessen Herstellung und dessen Verwendung |
PL362605A1 (en) | 2000-11-27 | 2004-11-02 | The Procter & Gamble Company | Dishwashing method |
US6630172B2 (en) | 2001-01-22 | 2003-10-07 | Kareem I. Batarseh | Microbicidal composition containing potassium sodium tartrate |
US7326420B2 (en) | 2001-03-06 | 2008-02-05 | Burkhart Craig G | Benzoyl peroxide compositions having increased potency |
GB0107366D0 (en) | 2001-03-23 | 2001-05-16 | Unilever Plc | Ligand and complex for catalytically bleaching a substrate |
US6939564B2 (en) | 2001-06-08 | 2005-09-06 | Labopharm, Inc. | Water-soluble stabilized self-assembled polyelectrolytes |
ES2189649B1 (es) * | 2001-06-15 | 2004-09-16 | Oftrai S.L. | Nueva composicion desinfectante y antiseptica. |
US20040234569A1 (en) | 2001-08-20 | 2004-11-25 | Kazuhiko Nakada | Disinfection method |
US20030185889A1 (en) | 2002-03-27 | 2003-10-02 | Jixiong Yan | Colloidal nanosilver solution and method for making the same |
US20030235623A1 (en) | 2002-06-21 | 2003-12-25 | Van Oosterom Piet J.A. | Aqueous disinfecting compositions with rapid bactericidal effect |
US6962714B2 (en) | 2002-08-06 | 2005-11-08 | Ecolab, Inc. | Critical fluid antimicrobial compositions and their use and generation |
US6827766B2 (en) | 2002-10-08 | 2004-12-07 | United States Air Force | Decontaminating systems containing reactive nanoparticles and biocides |
HUE045608T2 (hu) | 2003-06-06 | 2020-01-28 | Univ Texas | Antimikrobiális öblítõoldatok |
US7033511B2 (en) | 2004-01-20 | 2006-04-25 | A-Dec, Inc. | Sustained water treatment in dental equipment |
US6971945B2 (en) | 2004-02-23 | 2005-12-06 | Rohm And Haas Electronic Materials Cmp Holdings, Inc. | Multi-step polishing solution for chemical mechanical planarization |
US7494963B2 (en) | 2004-08-11 | 2009-02-24 | Delaval Holding Ab | Non-chlorinated concentrated all-in-one acid detergent and method for using the same |
WO2006034249A2 (en) * | 2004-09-20 | 2006-03-30 | Acrymed, Inc. | Antimicrobial amorphous compositions |
US20060079109A1 (en) * | 2004-10-04 | 2006-04-13 | Neal Castleman | Quick-disconnect threaded connector |
WO2006079109A2 (en) | 2005-01-21 | 2006-07-27 | Rdx Technologies, Inc. | Non-toxic antimicrobial compositions and methods using pro-oxidative polyphenols and antioxidants |
US7473675B2 (en) | 2005-02-25 | 2009-01-06 | Solutions Biomed, Llc | Disinfectant systems and methods comprising a peracid, alcohol, and transition metal |
US7534756B2 (en) | 2005-02-25 | 2009-05-19 | Solutions Biomed, Llc | Devices, systems, and methods for dispensing disinfectant solutions comprising a peroxygen and transition metal |
US7504369B2 (en) | 2005-02-25 | 2009-03-17 | Solutions Biomed, Llc | Methods and compositions for decontaminating surfaces exposed to chemical and/or biological warfare compounds |
WO2006093792A1 (en) | 2005-02-25 | 2006-09-08 | Solutions Biomed, Llc | Aqueous disinfectants and sterilants |
US7553805B2 (en) | 2005-02-25 | 2009-06-30 | Solutions Biomed, Llc | Methods and compositions for treating viral, fungal, and bacterial infections |
US7507701B2 (en) | 2005-02-25 | 2009-03-24 | Solutions Biomed, Llc | Aqueous disinfectants and sterilants including transition metals |
US7462590B2 (en) | 2005-02-25 | 2008-12-09 | Solutions Biomed, Llc | Aqueous disinfectants and sterilants comprising a peroxide/peracid/transition metal mixture |
-
2006
- 2006-08-24 US US11/510,516 patent/US7511007B2/en not_active Expired - Fee Related
-
2007
- 2007-08-22 AU AU2007295050A patent/AU2007295050B9/en not_active Ceased
- 2007-08-22 CN CNA2007800356438A patent/CN101516321A/zh active Pending
- 2007-08-22 CN CN201510115387.XA patent/CN104824019A/zh active Pending
- 2007-08-22 WO PCT/US2007/018606 patent/WO2008033206A1/en active Application Filing
- 2007-08-22 CA CA002661643A patent/CA2661643A1/en not_active Abandoned
- 2007-08-22 JP JP2009525624A patent/JP5337032B2/ja not_active Expired - Fee Related
- 2007-08-22 MX MX2009002090A patent/MX2009002090A/es active IP Right Grant
- 2007-08-22 BR BRPI0716584A patent/BRPI0716584A8/pt not_active IP Right Cessation
- 2007-08-22 EP EP07837233A patent/EP2063852A4/en not_active Withdrawn
- 2007-08-22 KR KR1020097005023A patent/KR101471684B1/ko not_active Expired - Fee Related
-
2009
- 2009-02-24 IL IL197207A patent/IL197207A0/en unknown
- 2009-03-09 ZA ZA2009/01673A patent/ZA200901673B/en unknown
-
2013
- 2013-05-21 JP JP2013106999A patent/JP2013155207A/ja not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1353574A (zh) * | 1999-04-23 | 2002-06-12 | 迪戈尔国际有限公司 | 基于h2o2、酸和金属离子的消毒组合物 |
EP1382666A1 (en) * | 2002-06-21 | 2004-01-21 | Tevan B.V. | Aqueous disinfecting compositions with rapid bactericidal effect |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113365597A (zh) * | 2019-01-14 | 2021-09-07 | 多米尼卡·托姆帕麦杰森 | 含有活性氧化合物的制剂及其应用装置 |
Also Published As
Publication number | Publication date |
---|---|
JP2010501569A (ja) | 2010-01-21 |
IL197207A0 (en) | 2009-12-24 |
BRPI0716584A2 (pt) | 2013-10-01 |
JP2013155207A (ja) | 2013-08-15 |
AU2007295050B9 (en) | 2012-09-20 |
CN101516321A (zh) | 2009-08-26 |
AU2007295050B2 (en) | 2012-05-03 |
US7511007B2 (en) | 2009-03-31 |
US20070053850A1 (en) | 2007-03-08 |
ZA200901673B (en) | 2010-02-24 |
EP2063852A4 (en) | 2013-03-06 |
JP5337032B2 (ja) | 2013-11-06 |
BRPI0716584A8 (pt) | 2015-11-24 |
MX2009002090A (es) | 2009-04-01 |
AU2007295050A1 (en) | 2008-03-20 |
WO2008033206A1 (en) | 2008-03-20 |
KR101471684B1 (ko) | 2014-12-10 |
CA2661643A1 (en) | 2008-03-20 |
KR20090045326A (ko) | 2009-05-07 |
EP2063852A1 (en) | 2009-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104824019A (zh) | 具有低过氧含量的水性卫生洗涤剂、消毒剂和/或杀菌剂 | |
CN101522033B (zh) | 消毒剂系统和方法 | |
JP4971198B2 (ja) | 水性消毒剤および滅菌剤 | |
US7462590B2 (en) | Aqueous disinfectants and sterilants comprising a peroxide/peracid/transition metal mixture | |
US20060199752A1 (en) | Aqueous disinfectants and sterilants including transition metals | |
CN102648710B (zh) | 复方戊二醛遗体消毒剂 | |
CN104106599A (zh) | 一种水性的消毒或灭菌组合物 | |
TWI405847B (zh) | 水性消毒劑與滅菌劑 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150812 |